T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.86B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.49B |
| 3 |
Broadcom
AVGO
|
+$1.29B |
| 4 |
Sempra
SRE
|
+$1.26B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$1.66B |
| 2 |
HCA Healthcare
HCA
|
+$1.02B |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$949M |
| 4 |
American Tower
AMT
|
+$931M |
| 5 |
FRC
First Republic Bank
FRC
|
+$890M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.29% |
| 2 | Technology | 17.01% |
| 3 | Financials | 16.32% |
| 4 | Consumer Discretionary | 14.01% |
| 5 | Industrials | 10.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
NN Inc
NNBR
$322M
| $477K | ﹤0.01% |
17,293
| – | – |
|
2102
M/I Homes
MHO
$3.87B
| $476K | ﹤0.01% |
13,836
-4,900
| -26% | -$160K |
|
2103
WD-40
WDFC
$3.08B
| $476K | ﹤0.01% |
4,036
-904
| -18% | -$104K |
|
|
EGRX
2104
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $476K | ﹤0.01% |
8,904
-23,234
| -72% | -$1.29M |
|
2105
Tactile Systems Technology
TCMD
$545M
| $474K | ﹤0.01% |
+16,366
| New | +$475K |
|
|
ARCH
2106
DELISTED
Arch Resources, Inc.
ARCH
| $474K | ﹤0.01% |
5,089
-386,088
| -99% | -$30.8M |
|
|
ALX
2107
Alexander's
ALX
$1.4B
| $469K | ﹤0.01% |
1,185
-201
| -15% | -$82.9K |
|
2108
DMC Global
BOOM
$154M
| $469K | ﹤0.01% |
18,739
-3,200
| -15% | -$65.7K |
|
|
HTZ
2109
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $463K | ﹤0.01% |
24,110
-40,504
| -63% | -$783K |
|
|
ASCMA
2110
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
| $463K | ﹤0.01% |
40,307
| – | – |
|
2111
OneMain Financial
OMF
$7.57B
| $461K | ﹤0.01% |
17,748
-2,780
| -14% | -$76.8K |
|
2112
Materion
MTRN
$5.99B
| $459K | ﹤0.01% |
9,450
-188,047
| -95% | -$8.94M |
|
2113
Genesco
GCO
$390M
| $456K | ﹤0.01% |
+14,044
| New | +$386K |
|
2114
Globalstar
GSAT
$10.6B
| $454K | ﹤0.01% |
23,090
+6,980
| +43% | +$159K |
|
2115
West Bancorporation
WTBA
$508M
| $454K | ﹤0.01% |
18,045
| – | – |
|
|
CORR
2116
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $454K | ﹤0.01% |
11,873
| – | – |
|
|
DOOR
2117
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $453K | ﹤0.01% |
6,106
-1,578
| -21% | -$110K |
|
|
NP
2118
DELISTED
Neenah, Inc. Common Stock
NP
| $453K | ﹤0.01% |
5,000
-1,900
| -28% | -$167K |
|
|
TBI
2119
Trueblue
TBI
$313M
| $451K | ﹤0.01% |
16,407
-10
| -0.1% | -$265 |
|
|
MAGN
2120
Magnera Corp
MAGN
$430M
| $451K | ﹤0.01% |
1,617
+231
| +17% | +$60.1K |
|
|
INFI
2121
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $451K | ﹤0.01% |
222,060
-45,400
| -17% | -$94.2K |
|
|
CHMI
2122
Cherry Hill Mortgage Investment Corp
CHMI
$109M
| $448K | ﹤0.01% |
+24,890
| New | +$456K |
|
2123
Mercury Systems
MRCY
$6.57B
| $448K | ﹤0.01% |
8,722
-10
| -0.1% | -$513 |
|
|
SIR
2124
DELISTED
SELECT INCOME REIT
SIR
| $448K | ﹤0.01% |
40,556
-23
| -0.1% | -$251 |
|
2125
Fortis
FTS
$28.8B
| $447K | ﹤0.01% |
12,133
+468
| +4% | +$17.3K |
|
Similar funds
T. Rowe Price Associates's Q4 2017 Portfolio in Review
As of Q4 2017, T. Rowe Price Associates held 2,692 positions worth $616B, up 5.3% from $585B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
T. Rowe Price Associates's Q4 2017 filing shows 121 new, 947 increased, 1,282 reduced and 130 closed positions. Its largest new stake was CarGurus: 13,060,603 shares worth $374M. The largest sale was PayPal, an estimated $1.66B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Technology and Financials.
- T. Rowe Price Associates's largest Q4 2017 buy was CarGurus: 13,060,603 shares worth $374M.
- T. Rowe Price Associates added most to Tesla in Q4 2017, an estimated $1.86B increase.
- T. Rowe Price Associates's biggest Q4 2017 reduction was PayPal, cutting an estimated $1.66B.
- T. Rowe Price Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $483M.
- T. Rowe Price Associates's ten largest holdings make up 19% of its $616B portfolio in Q4 2017.
- T. Rowe Price Associates opened 121 new positions and closed 130 in Q4 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $616B.
Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.